{"id":17378,"date":"2022-12-07T05:33:31","date_gmt":"2022-12-07T04:33:31","guid":{"rendered":"http:\/\/mabdesign.fr\/evidentic-new-international-member\/"},"modified":"2023-10-17T10:51:24","modified_gmt":"2023-10-17T08:51:24","slug":"evidentic-new-international-member","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/","title":{"rendered":"Evidentic &#8211; New International Member"},"content":{"rendered":"<p><strong><img decoding=\"async\" class=\"alignleft wp-image-9986 size-medium\" src=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png\" alt=\"Evidentic\" width=\"300\" height=\"73\" \/>Evidentic<\/strong> is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables. According to the chain of custody, transport, preparation, and storage conditions are documented. Our portfolio contains also different batches of the same API, licensed biosimilar drugs, and in-depth analytical data.\u00a0 <a href=\"https:\/\/evidentic.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">To know more<\/a><b><br \/>\n<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Evidentic is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables.<\/p>\n","protected":false},"author":1,"featured_media":7586,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33,36],"tags":[],"class_list":["post-17378","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-new-member","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Evidentic - New International Member - MabDesign<\/title>\n<meta name=\"description\" content=\"Evidentic is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evidentic - New International Member - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Evidentic is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-07T04:33:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-17T08:51:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2013\" \/>\n\t<meta property=\"og:image:height\" content=\"492\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"Evidentic &#8211; New International Member\",\"datePublished\":\"2022-12-07T04:33:31+00:00\",\"dateModified\":\"2023-10-17T08:51:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/\"},\"wordCount\":67,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png\",\"articleSection\":[\"New member\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/\",\"name\":\"Evidentic - New International Member - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png\",\"datePublished\":\"2022-12-07T04:33:31+00:00\",\"dateModified\":\"2023-10-17T08:51:24+00:00\",\"description\":\"Evidentic is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png\",\"width\":2013,\"height\":492},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evidentic &#8211; New International Member\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evidentic - New International Member - MabDesign","description":"Evidentic is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/","og_locale":"en_US","og_type":"article","og_title":"Evidentic - New International Member - MabDesign","og_description":"Evidentic is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables.","og_url":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/","og_site_name":"MabDesign","article_published_time":"2022-12-07T04:33:31+00:00","article_modified_time":"2023-10-17T08:51:24+00:00","og_image":[{"width":2013,"height":492,"url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png","type":"image\/png"}],"author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"Evidentic &#8211; New International Member","datePublished":"2022-12-07T04:33:31+00:00","dateModified":"2023-10-17T08:51:24+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/"},"wordCount":67,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png","articleSection":["New member","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/","url":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/","name":"Evidentic - New International Member - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png","datePublished":"2022-12-07T04:33:31+00:00","dateModified":"2023-10-17T08:51:24+00:00","description":"Evidentic is a provider of clinical-grade molecules from licensed drugs. We repackage mAbs, fusion proteins, ADCs, and other therapeutic molecules into drug aliquots for the use as research consumables.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/09\/evidentic_logos-01-5.png","width":2013,"height":492},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/evidentic-new-international-member\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Evidentic &#8211; New International Member"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=17378"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17378\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/7586"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=17378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=17378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=17378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}